Skip to main content

Risedronate News

FDA Medwatch Alert: Oral Osteoporosis Drugs (bisphosphonates): Drug Safety Communication - Potential Increased Risk of Esophageal Cancer

Includes: Fosamax (alendronate), Actonel (risedronate), Boniva (ibandronate), Atelvia (risedronate delayed release), Didronel (etidronate), and Skelid (tiludronate) ISSUE: FDA notified healthcare...

Warner Chilcott Announces FDA Approval of Atelvia - Next Generation Actonel

ARDEE, Ireland, October 11, 2010 /PRNewswire-FirstCall/ – Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its next generation Actonel...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Osteoporosis

Risedronate patient information at Drugs.com